Canada Digital Pathology Market Size & Outlook, 2023-2030
Canada digital pathology market, 2018-2030 (US$M)
Related Markets
Canada digital pathology market highlights
- The Canada digital pathology market generated a revenue of USD 77.5 million in 2023 and is expected to reach USD 131.4 million by 2030.
- The Canada market is expected to grow at a CAGR of 7.8% from 2024 to 2030.
- In terms of segment, device was the largest revenue generating product in 2023.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
Digital pathology market data book summary
| Market revenue in 2023 | USD 77.5 million |
| Market revenue in 2030 | USD 131.4 million |
| Growth rate | 7.8% (CAGR from 2023 to 2030) |
| Largest segment | Device |
| Fastest growing segment | Software |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software, Device, Storage Systems |
| Key market players worldwide | Danaher Corp, Hamamatsu Photonics KK, Koninklijke Philips NV, Olympus Corp, Roche Holding AG ADR, McCormick & Co Inc Registered Shs Non Vtg, Inspire Medical Systems Inc, PHC Holdings Corp, Huron Consulting Group Inc, CellaVision AB Bearer Shs, IBEX Ltd, Morphic Holding Inc, Nuvation Bio Inc Ordinary Shares - Class A |
Other key industry trends
- In terms of revenue, Canada accounted for 7.5% of the global digital pathology market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. digital pathology market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 131.4 million by 2030.
Device was the largest segment with a revenue share of 49.42% in 2023. Horizon Databook has segmented the Canada digital pathology market based on software, device, storage systems covering the revenue growth of each sub-segment from 2018 to 2030.
According to an article published by a lab informatics community, in 2017, the number of pathologists in Canada increased by 20.45% to 4.81 pathologists per 100,000 population. In January 2018, Inspirata, Inc., a digital pathology workflow and cancer informatics solution provider acquired Omnyx from GE Healthcare. Omnyx’s digital pathology software product Dynamyx is licensed by Health Canada and is CE-marked in Europe for IVD use.
On April 22, 2013, GE Healthcare (Mississauga, Ontario, Canada) announced that the Omnyx Integrated Digital Pathology system, developed jointly with the University of Pittsburgh Medical Center (Omnyx LLC, Pittsburgh, Pennsylvania), had obtained a Health Canada Class II Medical Device License for creating, managing, storing, annotating, measuring, and viewing digital whole slide images for routine pathology use.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Digital Pathology Market Scope
Digital Pathology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada digital pathology market size, by product, 2018-2030 (US$M)
Canada Digital Pathology Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
